FindTrial
Sign In

Incidence rate and molecular mechanism of peripheral PICC tube insertion combined with venous thromboembolism in patients with nasopharyngeal carcinoma

Incidence rate and molecular mechanism of peripheral PICC tube insertion combined with venous thromboembolism in patients with nasopharyngeal carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073906
Enrollment
Unknown
Registered
2023-07-25
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma was complicated with venous thrombosis

Interventions

Group without venous embolism:NA
Group with venous embolism:NA

Sponsors

Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) nasopharyngeal carcinoma, regardless of its etiology, pathology supports the diagnosis; (2) Age is over 18 years old; (3) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with incomplete clinical data. (2) History of limb fracture; (3) Patients with contraindications to anticoagulant drugs, and patients with serious liver and kidney diseases; (4) Patients with a history of venous thrombosis before admission; (5) Serious liver and kidney diseases; (6) Patients with other tumors.

Design outcomes

Primary

MeasureTime frame
blood platelet;contractinogen;prothrombin time ;Plasma partial prothrombin time;creatinine ;D-dimer ;—

Countries

China

Contacts

Public ContactLin Jiong

The Affiliated Hospital of Guangdong Medical University

1007489662@qq.com+86 183 0016 3986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026